NDC properties for "0.2 ML Humira 100 MG/ML Prefilled Syringe" (RxCUI 1921017)
About this data
The tables show NDC propoerties for 0.2 ML Humira 100 MG/ML Prefilled Syringe with the RxCUI 1921017
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.2 ML Humira 100 MG/ML Prefilled Syringe (RxCUI 1921017)
| BLA | BLA125057 |
|---|---|
| MMSL_CODE | BD33095 |
| RxCUI | 1921017 |
| SPL_SET_ID | 4977567e-3525-44ac-9ff5-f1e74b053950 |
| SPL_SET_ID | 608d4f0d-b19f-46d3-749a-7159aa5f933d |
| Prescribable Synonym | Humira 20 MG in 0.2 ML Prefilled Syringe |
| RXNAV_STR | 0.2 ML Humira 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.2 ML adalimumab 100 MG/ML Prefilled Syringe [Humira] |
| RxNorm Synonym | 0.2 ML Humira 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | Humira 20 MG per 0.2 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 1921017) |
NDC Properties
NDC Item 00074061602
| NDC 9 | 0074-0616 |
|---|---|
| NDC 10 | 0074-0616-02 |
| NDC Item | 00074061602 |
| Packaging | 2 KIT in 1 CARTON (0074-0616-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0616 |
NDC Item 00074061671
| NDC 9 | 0074-0616 |
|---|---|
| NDC 10 | 0074-0616-71 |
| NDC Item | 00074061671 |
| Packaging | 2 KIT in 1 CARTON (0074-0616-71) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0616 |
NDC Item 83457061501
| NDC 9 | 83457-615 |
|---|---|
| NDC 10 | 83457-615-01 |
| NDC Item | 83457061501 |
| Packaging | 0.2 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 83457-615 |
NDC Item 83457061602
| NDC 9 | 83457-616 |
|---|---|
| NDC 10 | 83457-616-02 |
| NDC Item | 83457061602 |
| Packaging | 2 KIT in 1 CARTON (83457-616-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-615-01) / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) |
| BLA | BLA125057 |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-02-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-616 |
NDC Item 00074061602
| NDC 9 | 0074-0616 |
|---|---|
| NDC 10 | 0074-0616-02 |
| NDC Item | 00074061602 |
| Packaging | 2 KIT in 1 CARTON (0074-0616-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0616 |
NDC Item 00074061671
| NDC 9 | 0074-0616 |
|---|---|
| NDC 10 | 0074-0616-71 |
| NDC Item | 00074061671 |
| Packaging | 2 KIT in 1 CARTON (0074-0616-71) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0616 |
NDC Item 83457061501
| NDC 9 | 83457-615 |
|---|---|
| NDC 10 | 83457-615-01 |
| NDC Item | 83457061501 |
| Packaging | 0.2 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 83457-615 |
NDC Item 83457061602
| NDC 9 | 83457-616 |
|---|---|
| NDC 10 | 83457-616-02 |
| NDC Item | 83457061602 |
| Packaging | 2 KIT in 1 CARTON (83457-616-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-615-01) / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) |
| BLA | BLA125057 |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-02-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-616 |
NDC Item 00074061602
| NDC 9 | 0074-0616 |
|---|---|
| NDC 10 | 0074-0616-02 |
| NDC Item | 00074061602 |
| Packaging | 2 KIT in 1 CARTON (0074-0616-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0616 |
NDC Item 00074061671
| NDC 9 | 0074-0616 |
|---|---|
| NDC 10 | 0074-0616-71 |
| NDC Item | 00074061671 |
| Packaging | 2 KIT in 1 CARTON (0074-0616-71) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0616 |
NDC Item 83457061501
| NDC 9 | 83457-615 |
|---|---|
| NDC 10 | 83457-615-01 |
| NDC Item | 83457061501 |
| Packaging | 0.2 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 83457-615 |
NDC Item 83457061602
| NDC 9 | 83457-616 |
|---|---|
| NDC 10 | 83457-616-02 |
| NDC Item | 83457061602 |
| Packaging | 2 KIT in 1 CARTON (83457-616-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-615-01) / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) |
| BLA | BLA125057 |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-02-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-616 |
NDC Item 00074061602
| NDC 9 | 0074-0616 |
|---|---|
| NDC 10 | 0074-0616-02 |
| NDC Item | 00074061602 |
| Packaging | 2 KIT in 1 CARTON (0074-0616-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0616 |
NDC Item 00074061671
| NDC 9 | 0074-0616 |
|---|---|
| NDC 10 | 0074-0616-71 |
| NDC Item | 00074061671 |
| Packaging | 2 KIT in 1 CARTON (0074-0616-71) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0074-0616 |
NDC Item 83457061501
| NDC 9 | 83457-615 |
|---|---|
| NDC 10 | 83457-615-01 |
| NDC Item | 83457061501 |
| Packaging | 0.2 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 83457-615 |
NDC Item 83457061602
| NDC 9 | 83457-616 |
|---|---|
| NDC 10 | 83457-616-02 |
| NDC Item | 83457061602 |
| Packaging | 2 KIT in 1 CARTON (83457-616-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-615-01) / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) |
| BLA | BLA125057 |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-02-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-616 |